Cross-modal fusion of cytomorphology and 18F-FDG PET/CT for non-invasive bone marrow immune microenvironment decoding in multiple myeloma - Top-Institutions - MDSpire

Cross-modal fusion of cytomorphology and 18F-FDG PET/CT for non-invasive bone marrow immune microenvironment decoding in multiple myeloma

  • By

  • Minjie Gao

  • Guifang Ouyang

  • Yangguang Liu

  • Shikun Chen

  • Kaihong Xu

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology

  • #2

    German-Speaking Myeloma Multicenter Group (GMMG)
    German-Speaking Myeloma Multicenter Group (GMMG)

    N/A, N/A

    Key Differentiators

    • Hematology

  • #3

    German Cancer Research Center
    German Cancer Research Center

    Heidelberg, BW

    Key Differentiators

    • Hematology

  • #4

    Kameda Medical Center
    Kameda Medical Center

    Kisarazu, Chiba

    Key Differentiators

    • Hematology

Original Source(s)

Cross-modal fusion of cytomorphology and 18F-FDG PET/CT for non-invasive bone marrow immune microenvironment decoding in multiple myeloma

  • by Minjie Gao, Guifang Ouyang, Yangguang Liu, Shikun Chen, Kaihong Xu

  • June 24, 2026

Related Content

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

  • April 27, 2026

  • 6 min
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee